From: Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia
 | B Value | Wald | Odds Ratio | 95% C.I. Lower | For OR Upper | P Value |
---|---|---|---|---|---|---|
Age | 0.005 | 0.142 | 1.005 | 0.981 | 1.029 | 0.707 |
BMI | -0.010 | 0.175 | 0.991 | 0.947 | 1.036 | 0.676 |
NIH Stroke Scale | -0.130 | 8.409 | 0.879 | 0.805 | 0.959 | 0.004* |
Risk of Mortality GWTG | 0.062 | 1.228 | 1.064 | 0.954 | 1.186 | 0.268 |
Race | 0.237 | 0.645 | 1.268 | 0.711 | 2.261 | 0.422 |
Atrial Fibrillation | 0.719 | 4.537 | 2.053 | 1.059 | 3.978 | 0.033* |
Coronary Artery Disease | 0.015 | 0.003 | 1.015 | 0.613 | 1.682 | 0.953 |
Carotid Artery Stenosis | 0.875 | 4.426 | 2.400 | 1.062 | 5.424 | 0.035* |
Diabetes | -0.035 | 0.007 | 0.965 | 0.420 | 2.217 | 0.934 |
Congestive Heart Failure | 0.431 | 1.297 | 1.539 | 0.733 | 3.230 | 0.255 |
Hypertension | -0.339 | 0.528 | 0.712 | 0.285 | 1.778 | 0.467 |
Previous Stroke | 0.579 | 4.798 | 1.785 | 1.063 | 2.998 | 0.028* |
Previous TIA | -0.256 | 0.576 | 0.774 | 0.400 | 1.500 | 0.448 |
Peripheral Vascular Disease | 0.377 | 0.704 | 1.457 | 0.605 | 3.512 | 0.401 |
History of Smoking | -0.426 | 1.986 | 0.653 | 0.361 | 1.181 | 0.159 |
Antiplatelet medication | -0.628 | 4.589 | 0.534 | 0.301 | 0.948 | 0.032* |
Antihypertensive medication | -0.321 | 0.679 | 0.725 | 0.338 | 1.557 | 0.410 |
Cholesterol Reducer | -0.226 | 0.562 | 0.798 | 0.442 | 1.441 | 0.454 |
Antidiabetic medication | 0.235 | 0.265 | 1.265 | 0.517 | 3.092 | 0.607 |